Press release
Neurodiagnostics Market is estimated to be US$ 7.22 billion by 2022 with a CAGR of 11.8% over the forecast period (2022-2032) With Top Most Key Players - GE Healthcare, Thermo Fisher Scientific Inc., Siemens Healthineers, Hoffman La Roche AG, Mitsar Co. L
Neurodiagnostics is the study of brain in which it records activity of brain & central nervous system to evaluate if it functions correctly. Various test are available in diagnosis of neurological disorder. Neurological diseases includes, Parkinson's disease, Alzheimer's disease, Huntington's disease, autism spectrum disorders, multiple sclerosis, and amyotrophic lateral sclerosis. There is rise in prevalence of neurological diseases worldwide. Diagnosis of neurological diseases includes various diagnostic methods like, EEG (electroencephalogram system), which helps in recording electrical activity of brain. Computed tomography (CT) scan is imaging technique which helps in capturing cross-sectional views of brain and surrounding structures and are widely used. Magnetic resonance imaging (MRI) helps in allowing visualization of soft tissues and structure of brain. Advancement in Biomarker technology has allowed to permit molecular measures which are taken from cerebrospinal fluid (CSF), brain, saliva, plasma, urine, etc. Different in-vitro diagnostic tools like immunoassays are most specific, sensitive, & selective technology used for interrogating protein based markers. Western blot, immunohistochemistry, ELISA (enzyme-linked immune-sorbent assay), CLIA (chemiluminescent immunoassay), LFIA (lateral flow immunoassay) are different types of in-vitro diagnostic immunoassays used for detection of biomarkers. Electromyography (EMG) and electroencephalogram system (EEG) are used in measuring nerve function and activity of brain by using small electric sensors. New technological advancement has given push in Neurodiagnostics market growth.To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Neurodiagnostics-Market-4983
The report "Neurodiagnostics Market, By Type (In-vitro Diagnostics, Imaging Systems, Molecular Diagnostics, Computed Tomography (CT), Electroencephalogram Systems, and Others), By End-Users (Hospitals, Clinics, Diagnostic Laboratories, Research Laboratories, Neurology Centers, Surgery Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"
Key Highlights:
• In March 2022, Siemens Healthineers has unveiled its new latest innovations in medical imaging at IRIA 2022 Bengaluru. Siemens Healthineers has introduced two unique solutions 'MAGNETOM Free.Star' and 'NAEOTOM Alpha' in CT and MRI portfolio. 'MAGNETOM Free.Star' is the scanner of new generation which is disruptively simple approach to MRI (magnetic resonance imaging) that used in transforming access to high value care. 'NAEOTOM Alpha' is the world's first photon counting CT and offers spectral information in each scan, high resolution images at minimal dose, and improve contrast at lower noise.
Analyst View:
The key factor driving the growth of the neurodiagnostics market is rising prevalence of neurological diseases, rising urban population which has led to unhealthy lifestyle, poor nutrition food, excess use of social media, lack of face to face communication, living alone, which has given rise in depression and dementia. Awareness about health among individual, high spending on healthcare due to disposal income, robust healthcare infrastructure with well-established equipment has given positive impact on neurodiagnostics market growth. However, rising neurological diseases and technological advancement in diagnostic techniques is anticipated to increase demand for neurodiagnostics during forecast period. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on"Neurodiagnostics Market, By Type (In-vitro Diagnostics, Imaging Systems, Molecular Diagnostics, Computed Tomography (CT), Electroencephalogram Systems, and Others), By End-Users (Hospitals, Clinics, Diagnostic Laboratories, Research Laboratories, Neurology Centers, Surgery Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"
Click To Get Sample Report:-
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4983
Segments Covered in the Report:
Neurodiagnostics Market, By Type:
• In-vitro Diagnostics
• Imaging Systems
• Molecular Diagnostics
• Computed Tomography (CT)
• Electroencephalogram Systems
• Others
Neurodiagnostics Market, By End-Users:
• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Laboratories
• Neurology Centers
• Surgery Centers
• Others
Key Market Insights from the report:
Neurodiagnostics Market accounted for US$ 7.22 billion in 2022 and is estimated to be US$ 17.8 billion by 2032 and is anticipated to register a CAGR of 11.8%. The Neurodiagnostics Market is segmented based on Type, End-Users and Region.
• Based on Type, Neurodiagnostics Market is segmented into In-vitro Diagnostics, Imaging Systems, Molecular Diagnostics, Computed Tomography (CT), Electroencephalogram Systems, and others.
• Based on End-Users, Neurodiagnostics Market is segmented into Hospitals, Clinics, Diagnostic Laboratories, Research Laboratories, Neurology Centers, Surgery Centers, and others.
• By Region, the Neurodiagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Competitive Landscape & their strategies of Neurodiagnostics Market:
The prominent players operating in the Neurodiagnostics Market includes, GE Healthcare, Thermo Fisher Scientific Inc., Siemens Healthineers, Hoffman La Roche AG, Mitsar Co. Ltd., QIAGEN, Canon Inc., Philips Healthcare, Bio-Rad Laboratories Inc., Combinostics, and others.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Other Related Reports:-
https://www.prophecymarketinsights.com/market_insight/Global-Electric-Toothbrush-Market-By-508
https://www.prophecymarketinsights.com/market_insight/Global-Medical-Tourism-Market-By-3800
https://www.prophecymarketinsights.com/market_insight/global-surgical-sutures-market-4527
964 E. BadilloStreet #2042 Covina, CA 91724
US toll free: +1 860 531 2701
Rest of world: + 91 7775049802
Email:sales@prophecymarketinsights.com
Website:www.prophecymarketinsights.com
About us:Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurodiagnostics Market is estimated to be US$ 7.22 billion by 2022 with a CAGR of 11.8% over the forecast period (2022-2032) With Top Most Key Players - GE Healthcare, Thermo Fisher Scientific Inc., Siemens Healthineers, Hoffman La Roche AG, Mitsar Co. L here
News-ID: 2814282 • Views: …
More Releases from Prophecy Market Insights

Power Purchase Agreement (PPA) Market Poised for Strong Growth Amid Rising Renew …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights
Introduction
The Power Purchase Agreement (PPA) Market is experiencing remarkable momentum, driven by the global transition toward renewable energy, carbon reduction targets, and rising demand for cost-effective electricity procurement models.
PPAs-long-term contracts between electricity producers and buyers-are becoming a critical mechanism for corporations, utilities, and governments to achieve energy security, price stability, and sustainability commitments. With the accelerating deployment of solar, wind, and…

Nutraceutical Packaging Market to Witness Robust Growth Amid Rising Health and W …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights
Introduction
The Nutraceutical Packaging Market is witnessing significant growth, fueled by rising consumer awareness around health, nutrition, and preventive healthcare. Nutraceuticals-ranging from dietary supplements and functional foods to vitamins, minerals, and herbal products-require specialized packaging that ensures shelf life, product integrity, safety, and consumer appeal.
With increasing demand for convenient, eco-friendly, and innovative packaging solutions, companies are investing in advanced materials, smart labeling,…

Japan Regulatory Affairs Outsourcing Market Set to Reach USD 0.4 Billion by 2035 …
Pune, India - September 5, 2025 - The Japan Regulatory Affairs Outsourcing Market is witnessing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on external partners for regulatory compliance. By 2035, the market is projected to reach USD 0.4 billion, rising from USD 0.3 billion in 2025, expanding at a CAGR of 7.71% during the forecast period.
Get a Sample Copy of Report :- https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5849
This growing demand underscores…

Europe Regulatory Affairs Outsourcing Market to Reach USD 4.2 Billion by 2035, D …
Pune, India - September 2, 2025 - The Europe Regulatory Affairs Outsourcing Market is experiencing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on specialized partners for regulatory compliance. According to recent analysis, the market size was valued at USD 2.0 billion in 2025 and is projected to expand to USD 4.2 billion by 2035, registering a CAGR of 7.70% during the forecast period.
Get Sample Copy of…
More Releases for Neurodiagnostics
Neurodiagnostics Market: Advancing Diagnostic Accuracy in Neurology
"In recent years, the global Neurodiagnostics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neurodiagnostics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Neurodiagnostics Market: Advancing Diagnostic Accuracy in Neurology
In recent years, the global Neurodiagnostics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neurodiagnostics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Neurodiagnostics Market Trends, Conditionrs, Restraints Forecast till 2030
The neurodiagnostics market encompasses a wide range of diagnostic tools and technologies used to diagnose neurological disorders and conditions, such as Alzheimer's disease, epilepsy, multiple sclerosis, and stroke. With the rising prevalence of neurological diseases and advancements in diagnostic technology, the market for neurodiagnostics is expanding rapidly. This article delves into the dynamic landscape of the global neurodiagnostics market, analyzing key trends, market drivers, challenges, regional insights, notable competitors, and…
Neurodiagnostics Market Share, Size Forecast till 2030
According to Ameco Research 'Neurodiagnostics Market report, the analysts took this into account when estimating the Neurodiagnostics Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Neurodiagnostics Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Neurodiagnostics Market trends, segmentation, key companies, SWOT, PORTER and…
Neurodiagnostics Market Size, Share and Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurodiagnostics Market Size, Share & Trends Analysis Report By Product (Diagnostic and Imaging Systems, Clinical Testing Instruments, Reagents & Consumables), By Condition (Neuro Degenerative Diseases, Epilepsy, Stroke), By End-Use (surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, and research laboratories & academic institutes)- Market Outlook And Industry Analysis 2031"
The global neurodiagnostic…
Neurodiagnostics Market Report Explored in Latest Research 2016 - 2023
Neurodiagnostics or neurodiagnostic tests monitor and record electrical activities of patient’s brain, spinal cord and peripheral nerves. The US National Institute of Mental Health (NIMH) estimates that approximately one in four individual suffers from diagnosable mental disorder each year. One in seventeen which is approximately 13.6 million people live with serious mental illnesses such as schizophrenia, major depression or bipolar disorder.
Request Brochure-
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10247
Serious mental illness costs the United States approximately USD…